FUSION ANTIBODIES
Fusion Antibodies specializes in production of high quality humanized monoclonal antibodies and antibody engineering projects. The company has the knowledge and expertise to build and deliver a bespoke package of the services people need to achieve outstanding results. Using the technology, the sequences of the antibody variable domains which determine its binding specificity are incorporated into human donor sequences creating a panel of full length humanized antibodies for expression. Fully ... humanized monoclonal antibodies are an essential step in the progression of your drug to the clinic and the in-house expertise at Fusion Antibodies ensures its success. All of Fusion Antibodies services are offered on a fee-for-service basis and is flexible on the elements of the project people would like included. Fusion Antibodies have strong links with the several partners around the globe, allowing it to deliver a complete bespoke package, at an incredible price. Fusion Antibodies was founded on 2001 and is based in Belfast, United Kingdom.
FUSION ANTIBODIES
Industry:
Biotechnology Clinical Trials Health Diagnostics Manufacturing Pharmaceutical
Founded:
2001-01-01
Address:
Belfast, Belfast, United Kingdom
Country:
United Kingdom
Website Url:
http://www.fusionantibodies.com
Total Employee:
11+
Status:
Active
Contact:
+44 28 9043 2800
Email Addresses:
[email protected]
Total Funding:
2.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins Nginx
Similar Organizations
GlycoVaxyn
GlycoVaxyn develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2012-05-23 | Selexis SA | Selexis SA acquired by Fusion Antibodies | N/A |
Investors List
Invest Northern Ireland
Invest Northern Ireland investment in Grant - Fusion Antibodies
Invest Northern Ireland
Invest Northern Ireland investment in Venture Round - Fusion Antibodies
University Challenge Fund
University Challenge Fund investment in Venture Round - Fusion Antibodies
Clarendon Fund Managers
Clarendon Fund Managers investment in Venture Round - Fusion Antibodies
Crescent Capital
Crescent Capital investment in Venture Round - Fusion Antibodies
QUBIS
QUBIS investment in Venture Round - Fusion Antibodies
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-28 | Fusion Antibodies Appoints Adrian Kinkaid CEO Effective Aug. 15 |
Official Site Inspections
http://www.fusionantibodies.com
- Host name: 104.248.167.225
- IP address: 104.248.167.225
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
